FindTrial
Sign In

Assessment of a bone breakdown marker in gum disease patients with Stage 1 high blood pressure.

Evaluation of crevicular levels of N Telopeptide in Hypertensive(stage 1) patients with Stage I and II periodontitis: A Prospective study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104753
Enrollment
60
Registered
2026-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Scaling and root planing: Scaling and root planing and measurement of crevicular levels of N-Telopeptide with periodontitis at baseline, 1 month, 3 month and 6 months Control Interventi

Sponsors

Dr Amol Ranjan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 30 to 50 years. 2. Individuals with Hypertension (Stage 1). 3. Individuals with Stage I-II periodontitis.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from any Systemic disease except hypertension 2. Pregnancy or Lactating women. 3. Surgical/Non-surgical periodontal treatment received in the past 6 months. 4. Patients taking antibiotics in last 3 months. 5. All forms of Tobacco users.

Design outcomes

Primary

MeasureTime frame
Comparison of N-Telopeptide levels between hypertensive patients with stage 1 periodontitis and those without periodontitisTimepoint: At baseline, 1 month, 3 month and 6 months—

Secondary

MeasureTime frame
N-Telopeptide levels in hypertensive patients with stage 1 periodontitisTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr Amol Ranjan

Manav Rachna Dental College, SDS, MRIIRS

nipundhalla.sds@mrei.ac.in913193692

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026